Stéphane Verguet
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stéphane Verguet.
The Lancet | 2015
John G. Meara; Andrew J M Leather; Lars Hagander; Blake C. Alkire; Nivaldo Alonso; Emmanuel A. Ameh; Stephen W. Bickler; Lesong Conteh; Anna J. Dare; Justine Davies; Eunice Dérivois Mérisier; Shenaaz El-Halabi; Paul Farmer; Atul A. Gawande; Rowan Gillies; Sarah L M Greenberg; Caris E. Grimes; Russell L. Gruen; Edna Adan Ismail; Thaim B. Kamara; Chris Lavy; Ganbold Lundeg; Nyengo Mkandawire; Nakul P Raykar; Johanna N. Riesel; Edgar Rodas; John Rose; Nobhojit Roy; Mark G. Shrime; Richard Sullivan
Remarkable gains have been made in global health in the past 25 years, but progress has not been uniform. Mortality and morbidity from common conditions needing surgery have grown in the world’s poorest regions, both in real terms and relative to other health gains. At the same time, development of safe, essential, life-saving surgical and anesthesia care in low- and middleincome countries (LMICs) has stagnated or regressed. In the absence of surgical care, case-fatality rates are high for common, easily treatable conditions including appendicitis, hernia, fractures, obstructed labor, congenital anomalies, and breast and cervical cancer. Although the term, low- and middleincome countries (LMICs), has been used throughout the report for brevity, the Commission realizes that tremendous income diversity exists between and within this group of countries. In 2015, many LMICs are facing a multifaceted burden of infectious disease, maternal disease, neonatal disease, noncommunicable diseases, and injuries. Surgical and anesthesia care are essential for the treatment of many of these conditions and represent an integral component of a functional, responsive, and resilient health system. In view of the large projected increase in the incidence of cancer, road traffic injuries, and cardiovascular and metabolic diseases in LMICs, the need for surgical services in these regions will continue to rise substantially from now until 2030. Reduction of death and disability hinges on access to surgical and anesthesiacare,whichshouldbeavailable, affordable,timely,andsafetoensuregood coverage, uptake, and outcomes. Despite a growing need, the develop
Health Economics | 2015
Stéphane Verguet; Ramanan Laxminarayan; Dean T. Jamison
Universal public finance (UPF)-government financing of an intervention irrespective of who is receiving it-for a health intervention entails consequences in multiple domains. First, UPF increases intervention uptake and hence the extent of consequent health gains. Second, UPF generates financial consequences including the crowding out of private expenditures. Finally, UPF provides insurance either by covering catastrophic expenditures, which would otherwise throw households into poverty or by preventing diseases that cause them. This paper develops a method-extended cost-effectiveness analysis (ECEA)-for evaluating the consequences of UPF in each of these domains. It then illustrates ECEA with an evaluation of UPF for tuberculosis treatment in India. Using plausible values for key parameters, our base case ECEA concludes that the health gains and insurance value of UPF would accrue primarily to the poor. Reductions in out-of-pocket expenditures are more uniformly distributed across income quintiles. A variant on our base case suggests that lowering costs of borrowing for the poor could potentially achieve some of the health gains of UPF, but at the cost of leaving the poor more deeply in debt.
The Lancet Global Health | 2015
Stéphane Verguet; C. Gauvreau; Sujata Mishra; Mary MacLennan; Shane M. Murphy; Elizabeth Brouwer; Rachel Nugent; Kun Zhao; Prabhat Jha; Dean T. Jamison
BACKGROUND In China, there are more than 300 million male smokers. Tobacco taxation reduces smoking-related premature deaths and increases government revenues, but has been criticised for disproportionately affecting poorer people. We assess the distributional consequences (across different wealth quintiles) of a specific excise tax on cigarettes in China in terms of both financial and health outcomes. METHODS We use extended cost-effectiveness analysis methods to estimate, across income quintiles, the health benefits (years of life gained), the additional tax revenues raised, the net financial consequences for households, and the financial risk protection provided to households, that would be caused by a 50% increase in tobacco price through excise tax fully passed onto tobacco consumers. For our modelling analysis, we used plausible values for key parameters, including an average price elasticity of demand for tobacco of -0·38, which is assumed to vary from -0·64 in the poorest quintile to -0·12 in the richest, and we considered only the male population, which constitutes the overwhelming majority of smokers in China. FINDINGS Our modelling analysis showed that a 50% increase in tobacco price through excise tax would lead to 231 million years of life gained (95% uncertainty range 194-268 million) over 50 years (a third of which would be gained in the lowest income quintile), a gain of US
The Lancet Global Health | 2015
Stéphane Verguet; Zachary Olson; Joseph B. Babigumira; Dawit Desalegn; Kjell Arne Johansson; Margaret E. Kruk; Carol Levin; Rachel Nugent; Clint Pecenka; Mark G. Shrime; Solomon Tessema Memirie; David Watkins; Dean T. Jamison
703 billion (
Surgery | 2015
John G. Meara; Andrew J M Leather; Lars Hagander; Blake C. Alkire; Nivaldo Alonso; Emmanuel A. Ameh; Stephen W. Bickler; Lesong Conteh; Anna J. Dare; Justine Davies; Eunice Dérivois Mérisier; Shenaaz El-Halabi; Paul Farmer; Atul A. Gawande; Rowan Gillies; Sarah L M Greenberg; Caris E. Grimes; Russell L. Gruen; Edna Adan Ismail; Thaim Buya Kamara; Chris Lavy; Lundeg Ganbold; Nyengo Mkandawire; Nakul P Raykar; Johanna N. Riesel; Edgar Rodas; John Rose; Nobhojit Roy; Mark G. Shrime; Richard Sullivan
616-781 billion) of additional tax revenues from the excise tax (14% of which would come from the lowest income quintile, compared with 24% from the highest income quintile). The excise tax would increase overall household expenditures on tobacco by
The Lancet | 2017
Felicia Marie Knaul; Paul Farmer; Eric L. Krakauer; Liliana De Lima; Afsan Bhadelia; Xiaoxiao Jiang Kwete; Héctor Arreola-Ornelas; Octavio Gómez-Dantés; Natalia M. Rodriguez; George Alleyne; Stephen R Connor; David J. Hunter; Diederik Lohman; Lukas Radbruch; María del Rocío Sáenz Madrigal; Rifat Atun; Kathleen M. Foley; Julio Frenk; Dean T. Jamison; M R Rajagopal; Huda Abu-Saad Huijer; Agnes Binagwaho; Snežana M Bošnjak; David M. Clark; James F. Cleary; José R Cossío Díaz; Cynthia Goh; Pascal J. Goldschmidt-Clermont; Mary Gospodarowicz; Liz Gwyther
376 billion (
The Lancet Global Health | 2016
Margaret E. Kruk; Hannah H Leslie; Stéphane Verguet; Godfrey Mbaruku; Richard Adanu; Ana Langer
232-505 billion), but decrease these expenditures by
Cost Effectiveness and Resource Allocation | 2013
Stéphane Verguet
21 billion (-
International Journal of Obstetric Anesthesia | 2016
John G. Meara; Andrew J M Leather; Lars Hagander; Blake C. Alkire; Nivaldo Alonso; Emmanuel A. Ameh; Stephen W. Bickler; Lesong Conteh; Anna J. Dare; Justine Davies; Eunice Dérivois Mérisier; Shenaaz El-Halabi; Paul Farmer; Atul A. Gawande; Rowan Gillies; Sarah L M Greenberg; Caris E. Grimes; Russell L. Gruen; Edna Adan Ismail; Thaim Buya Kamara; Chris Lavy; Ganbold Lundeg; Nyengo Mkandawire; Nakul P Raykar; Johanna N. Riesel; Edgar Rodas; John Rose; Nobhojit Roy; Mark G. Shrime; Richard Sullivan
83 to
PharmacoEconomics | 2016
Stéphane Verguet; Jane J. Kim; Dean T. Jamison
5 billion) in the lowest income quintile, and would reduce expenditures on tobacco-related disease by